xanthenes has been researched along with Alzheimer Disease in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghahsare, AG; Nazifi, SMR; Nazifi, ZS | 1 |
| Jha, AB; Panchal, SS; Shah, A | 1 |
| Amegadzie, A; Bartberger, MD; Brown, J; Chen, JJ; Chen, K; Cheng, AC; Cheng, Y; Dineen, TA; Dunn, RT; Epstein, O; Everds, NE; Fremeau, RT; Gore, V; Hickman, D; Hitchcock, SA; Human, J; Judd, TC; Kreiman, C; Liu, Q; Lopez, P; Ma, V; Marx, I; Minatti, AE; Patel, VF; Powers, TS; Qian, W; Vargas, HM; Vonderfecht, SL; Weiss, MM; Wen, PH; Werner, JA; White, RD; Whittington, DA; Wood, S; Xue, M; Yuan, C; Zhong, W | 1 |
| Albargothy, NJ; Carare, RO; Gatherer, M; Hawkes, C; Morris, A; Sharp, MM; Weller, RO | 1 |
| Burton, MA; Duong, S; Goldstein, LE; Hyman, B; Ingelsson, M; Kirby, JE; Moir, RD; Soscia, SJ; Tanzi, RE; Tucker, SM; Washicosky, KJ | 1 |
| Ehrlich, ME; Fraser, PE; Gandy, S; Kim, SH; St George-Hyslop, PH; Westaway, D | 1 |
| Battaglia, G; Britton, TC; Bruno, V; Cannella, M; Caraci, F; Copani, A; Drago, F; Giuffrida, ML; Heinz, BA; Merlo, S; Molinaro, G; Nicoletti, F; Nisenbaum, ES; Riozzi, B; Sortino, MA; Traficante, A; Wang, X | 1 |
| Chen, K; Cheng, AC; Dineen, TA; Epstein, O; Fremeau, RT; Graceffa, R; Hickman, D; Huang, H; Kiang, YH; La, DS; Louie, S; Luo, Y; Patel, VF; Wahl, RC; Wen, PH; Whittington, DA; Wood, S | 1 |
| Berezov, T; Boldyrev, A; Carpenter, DO; Koudinov, A | 1 |
| Du, G; Li, Z; Ni, K | 1 |
| Bondareff, W; Harrington, C; Hauser, DL; Roth, M; Wischik, CM | 1 |
1 review(s) available for xanthenes and Alzheimer Disease
| Article | Year |
|---|---|
Structure-Bioactivity Relationship Study of Xanthene Derivatives: A Brief Review.
Topics: Alzheimer Disease; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Biological Products; Drug Compounding; Drug Design; Humans; Hypoglycemic Agents; Molecular Structure; Structure-Activity Relationship; Xanthenes | 2019 |
10 other study(ies) available for xanthenes and Alzheimer Disease
| Article | Year |
|---|---|
Ellagic acid: Insights into its neuroprotective and cognitive enhancement effects in sporadic Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Cell Line, Tumor; Cholinesterase Inhibitors; Cognition; Donepezil; Ellagic Acid; Female; Free Radical Scavengers; Humans; Male; Maze Learning; Molecular Docking Simulation; Neuroprotective Agents; Oxazines; Rats; Rats, Wistar; Xanthenes | 2018 |
Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious β-secretase inhibitors for the potential treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Cell Line; HEK293 Cells; Humans; Protease Inhibitors; Rats; Xanthenes | 2015 |
Investigating the Lymphatic Drainage of the Brain: Essential Skills and Tools.
Topics: Alzheimer Disease; Animals; Cisterna Magna; Extracellular Fluid; Fixatives; Fluorescent Dyes; Formaldehyde; Hippocampus; Humans; Immunohistochemistry; Injections, Intraventricular; Lymphatic Vessels; Mice; Microscopy, Fluorescence; Parenchymal Tissue; Perfusion; Polymers; Stereotaxic Techniques; Tissue Embedding; Xanthenes | 2017 |
The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antimicrobial Cationic Peptides; Brain; Candida albicans; Cathelicidins; Cell Survival; Environment; Humans; Immunity, Innate; Inflammation; Ligands; Microbial Sensitivity Tests; Oxazines; Recombinant Proteins; Xanthenes | 2010 |
Group II metabotropic glutamate receptor stimulation triggers production and release of Alzheimer's amyloid(beta)42 from isolated intact nerve terminals.
Topics: Alzheimer Disease; Amino Acids; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Humans; Methoxyhydroxyphenylglycol; Mice; Mice, Transgenic; Nerve Endings; Peptide Fragments; Receptors, Metabotropic Glutamate; Signal Transduction; Xanthenes | 2010 |
Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 an
Topics: Alzheimer Disease; Amino Acids; Amyloid beta-Peptides; Animals; Antipsychotic Agents; Astrocytes; Bridged Bicyclo Compounds, Heterocyclic; Cells, Cultured; Mice; Mice, Knockout; Neurons; Neuroprotective Agents; Psychotic Disorders; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Transforming Growth Factor beta1; Xanthenes | 2011 |
Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer's disease.
Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Brain; Cell Line; Crystallography, X-Ray; Drug Design; Humans; Models, Molecular; Molecular Structure; Oxazoles; Peptide Fragments; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Xanthenes | 2012 |
Amyloid-beta induced cell death is independent of free radicals.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Animals; Animals, Newborn; Calcium; Carnosine; Cell Death; Cell Survival; Cerebellum; Dose-Response Relationship, Drug; Flow Cytometry; Fluorescent Dyes; Free Radicals; Indicators and Reagents; Intracellular Space; Kainic Acid; N-Methylaspartate; Neurons; Propidium; Rats; Reactive Oxygen Species; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Xanthenes | 2004 |
[Simultaneous analysis of six effective components in the anti-Alzheimer's disease effective component group of Xiao-Xu-Ming Decoction].
Topics: Alzheimer Disease; Animals; Benzoates; Benzylisoquinolines; Bridged-Ring Compounds; Chromatography, High Pressure Liquid; Drugs, Chinese Herbal; Flavonoids; Glucosides; Monosaccharides; Monoterpenes; Xanthenes | 2007 |
Immunohistochemical staging of neurofibrillary degeneration in Alzheimer's disease.
Topics: Alzheimer Disease; Antibodies; Epitopes; Fluorescein-5-isothiocyanate; Hippocampus; Humans; Immunohistochemistry; Microscopy; Nerve Degeneration; Neurofibrillary Tangles; Pronase; tau Proteins; Xanthenes | 1994 |